Institutional investors purchased a net $944.4 thousand shares of CPHD during the quarter ended June 2014 and now own 104.56% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CHAMPLAIN INVESTMENT PARTNERS LL... Bought 743.4 Thousand shares of Cepheid
WELLINGTON MANAGEMENT CO. LLP Bought 681.6 Thousand shares of Cepheid
FIDELITY MANAGEMENT & RESEARCH C... Bought 579.2 Thousand shares of Cepheid